Moreover, among tumor samples immunostained for activated Src (n = 35), KRASMUT CRC displayed higher levels of active Src, compared to KRASWT, either BRAFMUT or BRAFWT (Fig. 6B). This evidence concerns the gene SRC and neoplasm.